Abstract
ObjectivesTo examine the under-reporting of pharmaceutical company payments to patient organisations by donors and recipients.DesignComparative descriptive analysis of payments disclosed on drug company and charity regulator websites.SettingUK.Participants87 donors (drug companies)...
Highlights
►► We examine the under-reporting of pharmaceutical industry payments to patient organisations using large samples of donors and recipients over a period of time
Disclosure UK is a self-regulatory initiative run by the Association of the British Pharmaceutical Industry (ABPI), covering payments to healthcare organisations[32] and professionals,[33] but because its participants subscribe to the ABPI Code, they should separately disclose, on their websites, payments to patient organisations once a year.[1 15]
Our findings put a question mark over the key claim that—at least in their current form—publicly available payment disclosures effectively address concerns about conflict of interests (COIs) resulting from industry payments
Summary
Both donors[11] and recipients[4] assert that any COIs can be managed by careful disclosure of funding.
Sign-in/Register to view highlights & summary 
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call